What Does Thymosin Alpha-1 Do
A ten-minute explainer from a clinic founder on what thymosin alpha-1 is, how he says it modulates immune signaling, and where it is approved.
Key moments
Tap a moment to play the video from there.
- 0:00Discovery and video overviewArchibald says Dr. Goldstein found thymosin alpha-1 in 1977 and previews mechanisms, approvals and country use.
- 1:44Approval status and immune basicsHe says it is not FDA approved and its orphan status has expired, but it is approved in about 35 to 37 countries. He then sketches adaptive versus innate immunity and sex differences.
- 3:20The epic triggersHe lists emotional stress, chronic pain, infections and chemical exposures as stressors that downregulate immunity as the thymus shrinks with age.
- 4:40Immune resilience and T cell balanceHe describes the peptide as a 28 amino acid signal that binds white blood cells, and compares it to agencies sharing information.
- 6:49Cell danger response and mitochondriaHe ties the peptide to the mitochondrial cell danger response and says he adds mitochondrial peptides and methylene blue alongside it.
- 8:00Pattern recognition and add-onsHe mentions toll-like receptor pattern recognition, sternum tapping, and herbs like cordyceps, astragalus and ashwagandha.
- 8:55Approvals and clinical usesHe lists conditions it has been approved for abroad, including multiple sclerosis, hepatitis B and C, and chemotherapy support.
- 9:27Mechanistic review findingsHe cites a review that he says found the peptide is an immune modulator acting via MHC class one and toll-like receptor signaling, not a simple booster.
What the video says
Regan Archibald, who introduces himself as founder of Ageless Future, gives a short overview of thymosin alpha-1, a peptide made by the thymus gland. He opens with its history: he says Dr. Goldstein, working with George Washington University, found it in 1977 while studying molecules released by the thymus gland. He states that it is not currently FDA approved for any condition, that an orphan drug status has expired, and that it is approved in about 35 to 37 other countries under a brand name.
Archibald frames the immune system as having adaptive and innate arms and says adaptive responsiveness declines with age. He says the thymus is largest at birth and shrinks over time, and he lists what he calls the epic triggers that weaken immunity: emotional stress, chronic pain, infections and chemical exposures such as plastics, pollution, mold and pesticides. He also describes sex differences in immune behavior, linking women's autoimmunity risk to estrogen and men's acute disease risk to testosterone.
On mechanism, he describes thymosin alpha-1 as a 28 amino acid peptide that binds white blood cells and helps T cell balance and cell communication. He uses an analogy of agencies sharing information, and calls the peptide a traffic controller rather than a booster. He then connects it to the cell danger response in the mitochondria and suggests pairing it with mitochondrial peptides, methylene blue, herbs such as cordyceps, astragalus and ashwagandha, and tapping the sternum. These are his personal practices, not findings from studies.
Near the end he lists uses in other countries, including multiple sclerosis, hepatitis B and C, and support during chemotherapy, and mentions studies on COVID and other viral infections. He cites a mechanistic review from Albert Einstein College of Medicine and George Washington University, and says it concluded the peptide modulates T cell and cytokine responses through MHC class one and toll-like receptor signaling. No doses, protocols or data are given.
On each compound
Thymosin Alpha-10:00
Archibald describes it as a 28 amino acid peptide made by the thymus that he says acts as an immune modulator and signaling regulator rather than a booster. He says it is not FDA approved but is approved in about 35 to 37 countries.
See how your DNA reads Thymosin Alpha-1SS-316:49
Archibald says he adds SS-31 alongside thymosin alpha-1 as a mitochondrial peptide that he says helps protect the mitochondria.
See how your DNA reads SS-31Humanin6:49
Archibald names humanin among the mitochondrial peptides he says help protect mitochondria when used with thymosin alpha-1.
See how your DNA reads Humanin“It's just more of a traffic controller.”
What this video doesn’t settle
- No doses, schedules, routes of administration or side effects are discussed, so the video gives no way to judge how the peptide would be used.
- The cited mechanistic review is described only in passing, with no sample sizes, outcomes or effect sizes, and the placebo comparison is not explained.
- The sex-difference claims, the epic triggers framework and the add-ons such as herbs and sternum tapping are Archibald's own views, offered without supporting evidence.
Questions this video answers
What does thymosin alpha-1 do according to Regan Archibald?
Archibald says it is a signaling peptide that binds white blood cells and helps regulate T cell balance and communication. He calls it a traffic controller for the immune response rather than an immune booster.
Is thymosin alpha-1 FDA approved?
Archibald says it is not currently FDA approved for any condition and that its orphan drug status has expired. He says it is approved in about 35 to 37 other countries.
What conditions is thymosin alpha-1 approved for in other countries?
Archibald names multiple sclerosis, hepatitis B, hepatitis C and use as an adjunct during chemotherapy. He also says some studies have looked at COVID and other viral infections.
Who discovered thymosin alpha-1?
Archibald says Dr. Goldstein, working with George Washington University, discovered it in 1977 while studying molecules released by the thymus gland.
What does the cell danger response have to do with thymosin alpha-1?
Archibald says stressed mitochondria release ATP outside the cell to signal a threat, and he links the peptide to this process. He says he pairs it with mitochondrial peptides for that reason.
Video by Regan Archibald on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
